about
A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions.Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds.Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan.Iron(III) selective molecular and supramolecular fluorescent probes.Different approaches to the study of chelating agents for iron and aluminium overload pathologies.The meaning of aluminium exposure on human health and aluminium-related diseases.Chemical features of in use and in progress chelators for iron overload.An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions.Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives.A family of hydroxypyrone ligands designed and synthesized as iron chelators.Searching for new aluminium chelating agents: a family of hydroxypyrone ligands.Evaluation of a fibre optic device in solution equilibria studies. Application to 3-hydroxybenzoic acid ionization.Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators.Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.Manganese and cobalt binding in a multi-histidinic fragment.Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips.Changes in the characteristics of low affinity GABA binding sites elicited by Ro15-1788.Stress and beta-carbolines decrease the density of low affinity GABA binding sites; an effect reversed by diazepam.Editorial: Applications of Medicinal Bioinorganic Chemistry.Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine.Thermodynamic remarks on chelating ligands for aluminium related diseases.A study on the binding of diazepam to serum albumins by T1 NMR measurements.Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.Copper-related diseases: From chemistry to molecular pathologySilver coordination compounds: A new horizon in medicineToxicity of Nanoparticles: Etiology and MechanismsSubstituent effects on ionization constants as a predictive tool of coordinating abilityInteraction between aspergillic acid and iron(III): A potentiometric, UV–Vis, 1H NMR and quantum chemical studyA new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studiesHydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-oneEquilibrium study on Cd(II) and Zn(II) chelates of mercapto carboxylic acidsEquilibrium study on Pd(II) chelates of mercapto carboxylic acids3. Iron Chelation for Iron Overload in ThalassemiaLooking at new ligands for chelation therapypara-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metaboliteMetal coordination and tyrosinase inhibition studies with Kojic-βAla-KojicZinc(II) and copper(II) complexes with hydroxypyrone iron chelatorsKill or cure: Misuse of chelation therapy for human diseasesNoble metals in medicine: Latest advances
P50
Q35698528-A12ED69F-4D9F-4A1C-994F-8732637289E2Q36120540-BAB49FB3-8792-4838-A2EC-E4F25805E3E2Q36190787-0CF3CFD0-E15C-4272-9C81-9588ED0973F5Q38033982-254A07EF-F58E-49AD-8E4E-1583C2F57D13Q38055398-7A7614F2-4491-46EE-AAEA-83AA86957B08Q38273094-B3D0D0CF-015B-463B-96F9-244D598A53BDQ38882824-DF1DD9A1-2022-4975-8C12-4C974EE1A147Q41427338-42E2B693-75EC-44C4-A278-64517F3DE7C0Q42713986-2D9E0A7C-5F9E-4D43-AE01-31FAF11D87A6Q43149276-A5DEC619-9B1C-4C67-91AE-04E08069C58EQ43972283-FE05CD16-5968-4035-AE96-BF94D32275F7Q44703022-C02E2558-D089-47C5-B906-65766B0A66DCQ44944082-17603DFF-2929-4048-8058-20ED16ECB0DCQ46226714-63B374FD-7C1D-42D2-946C-E1EA75289E2DQ46864767-5CC45175-8585-4732-87CB-13F934735FCBQ46990744-615AB9FC-228A-439A-A3FE-7E3BFE0557F9Q47794244-AD837183-22D7-48B6-A4E9-FE6CBCB6E8B6Q48534458-9FD7FA42-7DBD-48A7-9BC2-93483BEA75B6Q48646539-710B2D78-A922-4261-859F-FBEC133AB938Q49600260-D61A9989-B6A6-460F-9242-C90FE7A69B16Q49834119-4CF5D9F5-5EAF-48E4-81FC-14E4BD6C5B93Q51494955-4AE3F04F-F0C0-46EB-8A47-DCCD124301E8Q51850837-8941ACC9-6686-4638-B016-7B85D92AFFD5Q52696614-E7523252-D1E1-4ED9-8D57-7F728E7DF3F0Q55884385-6609EEF3-A9A2-4D5A-A905-0318EE0997D2Q56138480-9DA665C0-EE05-42E1-85BB-B4BA4EF374AAQ56483164-E2DB19D9-7D19-4F2D-A48A-55C8E77FC566Q57251579-A49BB822-DBD8-40F2-9BCA-54E76D20F8A1Q58196912-C8C1EDA6-7F58-46AA-AEF6-E7019374A452Q59166605-DE40A885-9F12-45F4-8876-75608A734844Q59166620-92DD7CA0-5C00-4156-99AE-44446A737005Q61814492-47822554-9FA4-4973-AD72-34F956ED31CAQ61814504-A93CA080-5B9C-4743-B355-A76B6CD68156Q62016970-87EC3220-D226-49F3-9B44-BBB9555ECD2EQ62846634-6E41FE31-81AF-4452-A2AB-8A4549B38951Q62846687-C682F300-42B1-4005-A194-E9F98C4767F8Q62846788-6EF0214E-CA4B-4770-99C0-9EF699D24B84Q62846804-C1D5BAA1-6036-4C0F-8704-487465310BC3Q62846834-B2E0EF0B-D60F-48D1-A07B-AAF0B93A1F6BQ62846856-17ED6FF9-C368-4401-92DC-AC139BDF94BA
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Guido Crisponi
@ast
Guido Crisponi
@en
Guido Crisponi
@es
Guido Crisponi
@nl
Guido Crisponi
@sl
type
label
Guido Crisponi
@ast
Guido Crisponi
@en
Guido Crisponi
@es
Guido Crisponi
@nl
Guido Crisponi
@sl
prefLabel
Guido Crisponi
@ast
Guido Crisponi
@en
Guido Crisponi
@es
Guido Crisponi
@nl
Guido Crisponi
@sl
P214
P1053
G-2539-2014
P106
P1153
56566801100
7003668717
P21
P214
P31
P3829
P496
0000-0002-3902-0231
P735
P7859
lccn-n2016188962